P53-R273H mutation resulted in a much stronger tumor presence compared with p53-ctrl spheroid cells as assessed by a limiting dilution xenograft analysis (Fig. 2e), suggesting that p53-R273H mutation increased tumor initiating capacity. This evidence concerns the gene TP53 and neoplasm.